Účinek canagliflozinu na biomarkery kardiovaskulárního stresu u starších pacientů s diabetem 2. typu
Sattar N1, Januzzi JL2, Butler J3, Jarolim P4, Vijapurkar U5, Merton KW6, Ren J6, Canovatchel W5, Desai M5, Davies MJ6
1 BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
2 Massachusetts General Hospital, Harvard Medical School, Boston
3 Cardiology Division, Stony Brook University, Stony Brook
4 Brigham and Women‘s Hospital, Harvard Medical School, Boston
5 Janssen Research & Development, LLC, Raritan
6 Janssen Scientific Affairs, LLC, Titusville, USA
Akce: 53. výroční zasedání EASD Abstrakt číslo: 913 Autoři: Sattar N1, Januzzi JL2, Butler J3, Jarolim P4, Vijapurkar U5, Merton KW6, Ren J6, Canovatchel W5, Desai M5, Davies MJ6 1 BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK 2 Massachusetts General Hospital, Harvard Medical School, Boston 3 Cardiology Division, Stony Brook...